Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Retained Earnings (2021 - 2025)

PAVmed has reported Retained Earnings over the past 5 years, most recently at -$258.7 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$258.7 million for Q4 2025, down 1.48% from a year ago — trailing twelve months through Dec 2025 was -$258.7 million (down 1.48% YoY), and the annual figure for FY2025 was -$258.7 million, down 1.48%.
  • Retained Earnings for Q4 2025 was -$258.7 million at PAVmed, down from -$256.9 million in the prior quarter.
  • Over the last five years, Retained Earnings for PAVM hit a ceiling of -$97.8 million in Q1 2021 and a floor of -$320.6 million in Q2 2024.
  • Median Retained Earnings over the past 5 years was -$246.2 million (2023), compared with a mean of -$221.5 million.
  • Biggest five-year swings in Retained Earnings: plummeted 70.72% in 2022 and later grew 23.39% in 2025.
  • PAVmed's Retained Earnings stood at -$138.9 million in 2021, then plummeted by 64.26% to -$228.2 million in 2022, then decreased by 29.04% to -$294.4 million in 2023, then rose by 13.4% to -$255.0 million in 2024, then decreased by 1.48% to -$258.7 million in 2025.
  • The last three reported values for Retained Earnings were -$258.7 million (Q4 2025), -$256.9 million (Q3 2025), and -$250.6 million (Q2 2025) per Business Quant data.